Escalon Medical Corp. (ESMC)
OTCMKTS · Delayed Price · Currency is USD
0.1600
0.00 (0.00%)
Oct 31, 2025, 4:00 PM EDT
Escalon Medical Revenue
In the fiscal year ending June 30, 2025, Escalon Medical had annual revenue of $12.05M with 0.54% growth. Escalon Medical had revenue of $2.57M in the quarter ending June 30, 2025, a decrease of -25.97%.
Revenue
12.05M
Revenue Growth
+0.54%
P/S Ratio
0.10
Revenue / Employee
308.88K
Employees
39
Market Cap
1.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 12.05M | 64.64K | 0.54% |
| Jun 30, 2024 | 11.98M | -198.71K | -1.63% |
| Jun 30, 2023 | 12.18M | 1.48M | 13.80% |
| Jun 30, 2022 | 10.70M | 231.45K | 2.21% |
| Jun 30, 2021 | 10.47M | 1.07M | 11.40% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |